{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:28:36Z","timestamp":1753885716561,"version":"3.37.3"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0125665","type":"journal-article","created":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T13:52:27Z","timestamp":1430488347000},"page":"e0125665","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Factors Associated with Timing of Initiation of Antiretroviral Therapy among HIV-1 Infected Adults in the Niger Delta Region of Nigeria"],"prefix":"10.1371","volume":"10","author":[{"given":"Dimie","family":"Ogoina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finomo","family":"Finomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tubonye","family":"Harry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otonyo","family":"Inatimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikenna","family":"Ebuenyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolo-wolo","family":"Tariladei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abimbola Anne","family":"Afolayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,5,1]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendation for a public health approach 2013:1\u2013272. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\" xlink:type=\"simple\">www.who.int<\/ext-link> (accessed May 24, 2014)."},{"issue":"Suppl 2","key":"ref2","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1097\/QAD.0000000000000232","article-title":"Early initiation of antiretroviral therapy in HIV-infected adults and adolescents: a systematic review","volume":"28","author":"A Anglemyer","year":"2014","journal-title":"AIDS"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Siegfried N, Uthman OA, Rutherford GW. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Cochrane Database Syst Rev 2010:CD008272. <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1002\/14651858.CD008272.pub2\" xlink:type=\"simple\">10.1002\/14651858.CD008272.pub2<\/ext-link><\/comment>","DOI":"10.1002\/14651858.CD008272.pub2"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 Infection with Early Antiretroviral Therapy","volume":"365","author":"MS Cohen","year":"2011","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1056\/NEJMoa1110187","article-title":"Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy","volume":"368","author":"T Le","year":"2013","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMp1300458","article-title":"When to start ART in Africa\u2014an urgent research priority","volume":"368","author":"KM De Cock","year":"2013","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3851\/IMP2231","article-title":"Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysis","volume":"18","author":"X Anglaret","year":"2013","journal-title":"Antivir Ther"},{"key":"ref8","unstructured":"Federal Ministry of Health Nigeria. 2010 National HIV-seroprevalence sentinel survey. 2010."},{"key":"ref9","unstructured":"National Agency for Control of AIDS (NACA) Nigeria. Brief on the HIV response in Nigeria 2011:1\u20132. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.naca.gov.ng\" xlink:type=\"simple\">www.naca.gov.ng<\/ext-link> (accessed May 28, 2014)."},{"key":"ref10","unstructured":"Federal Ministry of Health Nigeria. National Guidelines for HIV AND AIDS Treatment and Care in Adolescents and Adults. 2010."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMoa0807252","article-title":"Effect of early versus deferred antiretroviral therapy for HIV on survival","volume":"360","author":"MM Kitahata","year":"2009","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/00002030-200207050-00009","article-title":"Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count &gt; 350 x 10(6) \/l","volume":"16","author":"M Opravil","year":"2002","journal-title":"AIDS"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00042560-200202010-00007","article-title":"Clinical and biological evolution of HIV-1 seroconverters in Abidjan, C\u00f4te d\u2019Ivoire, 1997\u20132000","volume":"29","author":"R Salamon","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1365-3156.2012.03089.x","article-title":"Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis","volume":"17","author":"C Mugglin","year":"2012","journal-title":"Trop Med Int Health"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"17424","DOI":"10.7448\/IAS.15.2.17424","article-title":"Patients\u2019 demographic and clinical characteristics and level of care associated with lost to follow-up and mortality in adult patients on first-line ART in Nigerian hospitals","volume":"15","author":"S Odafe","year":"2012","journal-title":"J Int AIDS Soc"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4236\/wja.2012.24044","article-title":"Retention in HIV Care among Patients Testing Positive for HIV and Ineligible to Start Antiretroviral Therapy","volume":"2","author":"KA Agu","year":"2012","journal-title":"World J AIDS"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/QAI.0b013e31829ceaec","article-title":"Risk factors for delayed initiation of combination antiretroviral therapy in rural north central Nigeria","volume":"65","author":"MH Aliyu","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e51254","DOI":"10.1371\/journal.pone.0051254","article-title":"The pattern of attrition from an antiretroviral treatment program in Nigeria","volume":"7","author":"S Odafe","year":"2012","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"17383","DOI":"10.7448\/IAS.15.2.17383","article-title":"Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review","volume":"15","author":"K Kranzer","year":"2012","journal-title":"J Int AIDS Soc"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2471\/BLT.06.037739","article-title":"True outcomes for patients on antiretroviral therapy who are \u201clost to follow-up\u201d in Malawi","volume":"85","author":"JK-L Yu","year":"2007","journal-title":"Bull World Health Organ"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/jac\/43.3.379","article-title":"Are HIV-infected patients with rapid CD4 cell decline a subgroup who benefit from early antiretroviral therapy?","volume":"43","author":"PJ Easterbrook","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1017\/S095026889800140X","article-title":"The rate of CD4 decline as a determinant of progression to AIDS independent of the most recent CD4 count","volume":"121","author":"C Lepri","year":"1998","journal-title":"Epidemiol Infect"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e1001270","DOI":"10.1371\/journal.pmed.1001270","article-title":"Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis","volume":"9","author":"AB Suthar","year":"2012","journal-title":"PLoS Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2174\/157016211798038597","article-title":"Antiretroviral therapy in prevention of HIV and TB: update on current research efforts","volume":"9","author":"R Granich","year":"2011","journal-title":"Curr HIV Res"},{"key":"ref25","first-page":"233","article-title":"The HIV\/AIDS epidemic in Nigeria: progress, problems and prospects","volume":"39","author":"MH Aliyu","year":"2010","journal-title":"Afr J Med Med Sci"},{"key":"ref26","unstructured":"National Agency for Control of AIDS (NACA) Nigeria. Fact Sheet: Update on the HIV\/AIDS Epidemic and Response in Nigeria 2011:1\u201317. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.naca.gov.ng\" xlink:type=\"simple\">www.naca.gov.ng<\/ext-link>. Accessed 2014 May 28."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-6405-4-11","article-title":"Predictors of disease progression in HIV infection: a review","volume":"4","author":"SE Langford","year":"2007","journal-title":"AIDS Res Ther"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0125665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T04:38:47Z","timestamp":1540010327000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0125665"}},"subtitle":[],"editor":[{"given":"Weijing","family":"He","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,1]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0125665","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2015,5,1]]}}}